Company / Cash per Share
CUMBERLAND PHARMACEUTICALS INC Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$0.82
FY2025
5-year range
$0.82 / $1.80
FY2021-FY2025
Trend
-35.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Cash per Share has declined for 4 consecutive years, from $1.80 in FY2021 to $0.82 in FY2025.
Based on SEC 10-K filings.
0.82 in FY2025 with a 5-year CAGR of -12.7%.
Declined from $1.28 to $0.82 over the past 2 years.
Cash per Share over time
Growth rates
- 3-Year CAGR
- -15.1%
- 5-Year CAGR
- -12.7%
- 10-Year CAGR
- -
Key checks
Key Insights
- CUMBERLAND PHARMACEUTICALS INC's cash per share has declined for 4 consecutive years.
- In FY2025, cash per share decreased 35.5% year-over-year.
- Peak cash per share was recorded in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.82 | -35.5% |
| FY2024 | $1.27 | -0.3% |
| FY2023 | $1.28 | -4.8% |
| FY2022 | $1.34 | -25.7% |
| FY2021 | $1.80 | +11.2% |
| FY2020 | $1.62 | -11.0% |
| FY2019 | $1.82 | -35.5% |
| FY2018 | $2.83 | +18.9% |
| FY2017 | $2.38 | -2.4% |
| FY2016 | $2.43 | +1.9% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026